Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

Life after LIFE. Cardiovascular benefits of angiotensin II receptor blockade in older people with essential hypertension, left ventricular hypertrophy and diabetes mellitus

By Giacomelli V.O.   Singer D.R.J.  

European Journal of Internal Medicine, Vol. 13, Iss. 6, 2002-09 ,pp. : 353-355

Elsevier

Access to resources Recommend Favorite

The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin–angiotensin system

By Reuter H.   Adam C.   Grönke S.   Zobel C.   Frank K.   Müller-Ehmsen J.   Brabender J.   Schwinger R.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3067-3074

Springer Publishing Company

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite